Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE3
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Genetic Predictors of Benefit to Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE2
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
- Status
- TERMINATED
- Phase
- PHASE1
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Denosumab as an add-on Neoadjuvant Treatment (GeparX)
- Status
- COMPLETED
- Phase
- PHASE2
ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173)
- Status
- COMPLETED
- Phase
- PHASE1
Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2